Showing results (81-90 of 773) with videos related to
Sort By:
Pageof 78
JAMA|August 24, 2016
The High Cost of Prescription Drugs in the United States: Origins and Prospects for ReformAaron S Kesselheim, Jerry Avorn, Ameet SarpatwariValue in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 15, 2011
The association between statin use and outcomes potentially attributable to an unhealthy lifestyle in older adultsAmanda R Patrick, William H Shrank, Robert J Glynn, et al.The Milbank Quarterly|December 3, 2015
Do March-In Rights Ensure Access to Medical Products Arising From Federally Funded Research? A Qualitative StudyCarolyn L Treasure, Jerry Avorn, Aaron S KesselheimCirculation. Cardiovascular Quality and Outcomes|December 25, 2009
Cost-effectiveness of genotype-guided warfarin dosing for patients with atrial fibrillationAmanda R Patrick, Jerry Avorn, Niteesh K ChoudhryHealth Affairs (Project Hope)|November 15, 2006
Extensions of intellectual property rights and delayed adoption of generic drugs: effects on medicaid spendingAaron S Kesselheim, Michael A Fischer, Jerry AvornJAMA|August 3, 2021
FDA Regulation and Approval of Medical Devices: 1976-2020Jonathan J Darrow, Jerry Avorn, Aaron S KesselheimBMJ (Clinical Research Ed.)|October 25, 2019
Public sector financial support for late stage discovery of new drugs in the United States: cohort studyRahul K Nayak, Jerry Avorn, Aaron S KesselheimPlos Medicine|June 2, 2011
Medical students' exposure to and attitudes about the pharmaceutical industry: a systematic reviewKirsten E Austad, Jerry Avorn, Aaron S KesselheimHealth Affairs (Project Hope)|October 6, 2010
Designing comparative effectiveness research on prescription drugs: lessons from the clinical trial literatureDave A Chokshi, Jerry Avorn, Aaron S KesselheimJAMA Network Open|January 25, 2023
Variation in Use of Lung Cancer Targeted Therapies Across State Medicaid Programs, 2020-2021Thomas J Roberts, Aaron S Kesselheim, Jerry AvornPageof 78